产品
编 号：F757441
分子式：C20H16BrNO5S
分子量：462.31
分子式：C20H16BrNO5S
分子量：462.31
产品类型
规格
价格
是否有货
10mM*1mL in DMSO
询价
询价
5mg
询价
询价
10mg
询价
询价
25mg
询价
询价
50mg
询价
询价
结构图
CAS No: 324022-08-4
产品详情
生物活性：
EBNA1-IN-SC7 (compound SC7) is a selective Epstein-Barr nuclear antigen 1 (EBNA1) inhibitor that interferes with EBNA1-DNA binding activity with an IC50 value of 23 μM. EBNA1-IN-SC7 is used in EBV (Epstein-Barr virus)-related cancer research.
体外研究：
EBNA1-IN-SC7 (compound SC7) (5 μM) can completely block transcriptional activation of EBNA1 and show a 60% inhibition of Zta (EBV-encoded b-zip DNA binding protein) trans-activation in HEK293T cells.EBNA1-IN-SC7 (compound SC7) (10 μM, 6 days) has no significant effect on EBV genome copy number of Raji Burkitt lymphoma cells.
EBNA1-IN-SC7 (compound SC7) is a selective Epstein-Barr nuclear antigen 1 (EBNA1) inhibitor that interferes with EBNA1-DNA binding activity with an IC50 value of 23 μM. EBNA1-IN-SC7 is used in EBV (Epstein-Barr virus)-related cancer research.
体外研究：
EBNA1-IN-SC7 (compound SC7) (5 μM) can completely block transcriptional activation of EBNA1 and show a 60% inhibition of Zta (EBV-encoded b-zip DNA binding protein) trans-activation in HEK293T cells.EBNA1-IN-SC7 (compound SC7) (10 μM, 6 days) has no significant effect on EBV genome copy number of Raji Burkitt lymphoma cells.
产品资料
Copyright©2015-2024 沪ICP备2022026524号-1
沪公网安备